| Zugriffe | |
|---|---|
| Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study | 240 |
| Januar 2025 | Februar 2025 | März 2025 | April 2025 | Mai 2025 | Juni 2025 | Juli 2025 | |
|---|---|---|---|---|---|---|---|
| Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study | 5 | 10 | 3 | 3 | 16 | 7 | 2 |
| Zugriffe | |
|---|---|
| 2021_Correll_etal.pdf | 7485 |
